Description

Salofalk (mesalazine) rectal suspension 4 g/60 g. №7 in enemas

Ingredients

Each enema contains 4 g of mesalazine in a 60 g suspension.

Dosage

The usual dose is one enema (4 g) at bedtime and retained overnight. Consult your healthcare provider for personalized dosing instructions.

Indications

Salofalk enemas are indicated for the treatment of ulcerative colitis, proctitis, and proctosigmoiditis.

Contraindications

Do not use Salofalk enemas if you are allergic to mesalazine or any other ingredients in the product.

Directions

Shake the enema well before use. Lie on your left side with your right knee bent. Gently insert the applicator tip into the rectum and squeeze the bottle to release the suspension. Retain the enema for as long as possible.

Scientific Evidence

Studies have shown that mesalazine, the active ingredient in Salofalk enemas, is effective in inducing and maintaining remission in patients with ulcerative colitis. Research published in the Journal of Gastroenterology demonstrated the superior efficacy of mesalazine enemas compared to placebo in reducing symptoms and inflammation in the colon.

Additional Information

Salofalk enemas work locally in the colon to reduce inflammation and symptoms associated with ulcerative colitis. By delivering the medication directly to the affected area, systemic side effects are minimized. Clinical trials have shown that mesalazine enemas are well-tolerated and can improve quality of life for patients with inflammatory bowel disease.